Answers are grounded in this paper and cite their sources.
Retrospective study assesses infliximab efficacy in pediatric uveitis, indicating a promising option for treatment.
Introduction: This retrospective study aims to assess the efficacy of infliximab by intravenous infusion in treating pediatric non-infectious uveitis, including as a second-line anti-tumor necrosis factor (TNF) for patients with insufficient control from adalimumab.
No takes yet. Share an insight, caveat, or question.
Reekie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: